U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807619) titled 'A Study of Sotorasib in People With Brain Tumors' on Jan. 29.
Brief Summary: The researchers are doing this study to find out how effective sotorasib is at getting into KRAS G12C+ brain tumors. The researchers will also find out whether sotorasib is a safe and effective treatment for people undergoing surgical resection of KRAS G12C+ metastatic brain tumors, and do tests that show how the body absorbs, distributes, and gets rid of sotorasib.
Study Start Date: Jan. 29
Study Type: INTERVENTIONAL
Condition:
Brain Tumor
Intervention:
DRUG: Sotorasib
Enrolled patients will be administered DCOI at the FDA-recommended dose or continu...